Chicago-based GE HealthCare said Thursday it is spending $2.3 billion in cash to acquire Intelerad, a Montreal-based medical imaging software maker, as part of a push to expand its cloud and AI imaging offerings. The deal is one of the largest moves by the company since its 2023 spinout and pushes GE deeper into outpatient and ambulatory imaging markets.
In a press release on Business Wire, GE HealthCare said the acquisition is intended to create a cloud‑first imaging ecosystem that pulls together its hospital tools with Intelerad’s outpatient and teleradiology software, helping accelerate the shift toward software‑as‑a‑service and recurring revenue. The company said the move will help it "triple" cloud‑enabled products by 2028 and speed adoption of its AI portfolio, according to the release.
Deal terms and timing
Reuters reported the purchase price is $2.3 billion paid in cash and that GE expects Intelerad to contribute about $270 million in revenue in the first full year after closing. The transaction is subject to customary closing conditions and regulatory approvals and is expected to close in the first half of 2026. Intelerad’s majority owners, Hg Capital and TA Associates, will fully exit through the sale, the report says.
What Intelerad brings
Intelerad, founded in 1999, is known for cloud PACS, workflow orchestration, and image‑sharing tools used by outpatient clinics and teleradiology groups, with cloud‑native products built to support recurring revenue for buyers. The company lists offices in Montreal and across North America and Europe, according to Intelerad, and GE said the acquisition expands its footprint into outpatient imaging networks, per the company announcement on Business Wire.
Market reaction and investor view
Bloomberg reports GE HealthCare shares slipped less than 1% in after‑hours trading as analysts weighed the near‑term financing impact against longer‑term gains in recurring revenue and margin. The outlet also described the Intelerad purchase as the largest deal GE HealthCare has announced since its 2023 spinout, highlighting management’s push into software and AI.
What’s next
GE HealthCare said it will fund the deal with cash and debt and that financing costs will be slightly dilutive to adjusted profit in the short term, a hit the company plans to offset with efficiencies, according to a company filing on Nasdaq. TA Associates confirmed that its and Hg’s stakes will be exited as part of the transaction in a statement published today, and advisers to the deal have been named by the parties.
For Chicago, the deal reinforces the city’s role in a health‑technology rebound after GE’s 2023 breakup and puts more financial muscle behind the company’s software push, local analysts said. Crain's Chicago Business covered the announcement and highlighted the local ties of GE HealthCare's leadership and headquarters.
